fold decrease in maximal contractile response to noradrenaline, 3.5 fold decrease in maximal relaxation response to acetylcholine). (253 words)
INTRODUCTION
Endothelin (ET)-1, a 21-amino acid peptide released by endothelial cells, is a potent vasoconstrictor that may play a role in the pathogenesis of cardiovascular diseases as diverse as hypertension, chronic heart failure, ischaemic heart disease, atherosclerosis and chronic renal failure Masaki, 2004) . ET-1 activates ET-A and ET-B receptors; non-selective endothelin receptor antagonists such as bosentan attenuated left ventricular remodelling and improved survival in rats with coronary artery ligation (Mulder et al., 1997) . However, early intervention with the high affinity non-selective ET receptor antagonist, SB 209670, promoted left ventricular dilatation without altering infarct size or collagen composition (Øie et al., 2002) . Using the same model, treatment with the selective ET-A antagonist, LU 135252 (30 mg kg -1 day -1 ), for 9 months improved cardiac function measured by echocardiography and decreased left ventricular collagen density but did not improve long-term survival (Mulder et al., 2002) .
These potential therapeutic benefits of endothelin receptor antagonists were defined using rat models of cardiovascular disease, in particular the coronary artery ligation model of myocardial infarction and heart failure. Other studies with endothelin receptor antagonists have used the deoxycorticosterone acetate (DOCA)-salt hypertensive rat. These rats develop hypertension, cardiac hypertrophy and fibrosis together with over-expression of endothelin by vascular cells and cardiac endothelial cells suggesting that endothelin plays an important role in these structural and functional changes (Schiffrin, 2001 ). In this model, administration of the ET-A receptor selective antagonist, A-127722 (30 mg kg -1 day -1 ), as a prevention protocol produced a small decrease in blood pressure with no change in heart weight but normalised procollagen expression and prevention of cardiac collagen deposition (Ammarguellat et al., 2001) . Further, the increase in fibronectin deposition, matrix metalloproteinase activity and upregulation of inflammatory mediators was reduced following ET-A receptor antagonism with BMS 182874 (40 mg kg -1 day -1 ), another selective ET-A receptor antagonist (Ammarguellat et al., 2002) . This ET-A receptor selective antagonist reduced cardiac macrophage content and decreased expression of cell adhesion molecules in DOCA-salt hypertensive rats (Callera et al., 2004) .
DOCA-salt hypertensive rats also developed prolongation of the action potential duration (Momtaz et al., 1996) ; endothelin produced similar prolongation (Yorikane et al., 1991) that was blocked by the selective ET-A receptor antagonist, BQ-123 (Garjani et al., 1995) . Endothelial dysfunction developed in DOCA-salt hypertensive rats and was prevented by administration of apocynin, an inhibitor of NADPH oxidase (Beswick et al., 2001) or the antioxidant, sesamin (Nakano et al., 2003) .
Increases in reactive oxygen species, especially superoxide produced by NADPH oxidase, may underlie the development of hypertension and cardiovascular remodelling in DOCA-salt rats (Beswick et al., 2001; Li et al., 2003) . Reactive oxygen species can initiate free radical chain reactions resulting in membrane and cell damage; this has been proposed as the cause of cardiovascular damage (Sawyer et al., 2002) . The major source of superoxide production in the vasculature is NADPH oxidase (Li & Shah, 2004) . The most likely mechanism for NADPH oxidase activation in DOCA-salt hypertensive rats is an increased endothelin-1 concentration acting through ET-A receptors since selective blockade of ET-A receptors reduced arterial superoxide formation and improved structure and function (Callera et al., 2003; Li et al., 2003; Pu et al., 2003) .
This study has used a reversal protocol (oral administration of A-127722 for 2 weeks started 2 weeks after initiation of DOCA-salt hypertension) to determine whether antagonism of ET-A receptors reverses existing changes and possibly prevents further cardiovascular remodelling, thus improving cardiovascular function. We have used echocardiography to define cardiac function in vivo and the isolated Langendorff heart to define function ex vivo. Single cell microelectrode studies on isolated left ventricular papillary muscles were used to determine changes in cardiac action potentials. Isolated thoracic aortic rings were used to examine endothelial dysfunction in DOCA-salt vessels. Collagen deposition was defined using laser confocal microscopy of picrosirius red-stained slices. (Dallemagne et al., 2000) . Experiments were performed 14 or 28 days after surgery. After 14 days, rats were given A-127722 (200 mg kg -1 powdered food) for a further 14 days.
METHODS

DOCA-salt hypertensive rats
Assessment of physiological parameters
Food and water intake and body weights were measured daily for all rats. Systolic blood pressure and heart rate were measured in a subgroup of rats lightly anaesthetised with Zoletil® (tiletamine 15mg kg -1 ip with zolazepam 15mg kg -1 ip) using a tail pulse transducer (MLT1010) and an inflatable tail cuff with a Capto SP844 physiological pressure transducer (MLT844/D) connected to a PowerLab data acquisition unit (ADInstruments, Sydney, Australia). Rats were killed with pentobarbitone (200 mg kg -1 ip). Blood was taken from the abdominal vena cava, centrifuged and the plasma frozen.
Echocardiography
Serial, in vivo left parasternal and left apical echocardiographic images of rats were obtained using the Hewlett Packard Sonos 5500 (12MHz frequency fetal transducer)
at an image depth of 3 cm using two focal zones (Litwin et al., 1994) . Pulsed-wave Doppler analyses of mitral valve inflows were used as estimates of diastolic function.
Isolated heart preparations
The non-recirculating Langendorff heart preparation was used for isolated myocardial experiments (Brown et al., 1999) . Briefly, rats were anaesthetised with pentobarbitone sodium (100 mg kg -1 ip). The right leg femoral vein was exposed and
heparin ( defined by the stiffness constant (k, dimensionless) that is the slope of the linear relation between the tangent elastic modulus (E, dyne cm -2 ) and stress (σ, dyne cm -2 ) (Brown et al., 1999) . To assess contractile function, maximal +dP/dt values were calculated at a diastolic pressure of 10 mmHg. At the end of the experiment, the atria were removed and the weight of the ventricles plus septum was recorded.
Microelectrode studies on isolated left ventricular papillary muscles
Rats were anaesthetised by CO 2 inhalation and then euthanased by exsanguination.
The thorax was opened quickly and the heart was removed. and 5% CO 2 . A stainless steel hook was placed in one end of the papillary muscle.
The muscle was placed in a 1.0 mL experimental chamber continuously perfused with gassed warm Tyrode solution at 3 mL min -1 (35±0.5°C) and was fixed at the other end with a small stainless steel pin embedded into a rubber base. The hook was attached to a modified sensor element (SensoNor AE801) connected to an amplifier (World Precision Instruments. TBM-4). The muscle was slowly stretched to maximum preload over one minute. Contractions were induced by field stimulation (Grass SD-9) via electrodes on either side of the muscle (stimulation frequency 1 Hz, pulse width 0.5 msec; stimulus strength 20% above threshold).
After maximum preload was attained, the muscle was allowed to equilibrate for a further 45 min before impalement with a glass microelectrode (World Precision Instruments, filamented borosilicate glass, outer diameter 1.5 mm) that had a tip resistance of 5-15 mΩ when filled with 3 M KCl. The reference electrode was an Ag/AgCl electrode. A Cyto 721 electrometer (World Precision Instruments) was used to record bioelectrical activity. All signals were recorded via a PowerLab 4S data acquisition unit (ADInstruments, Sydney, Australia). Preparations were accepted that had a stable resting potential more negative than -60 mV. Continual impalement throughout an experiment was not always possible, however, if displacement occurred, then the results of a subsequent impalement were accepted provided the data fitted the criteria described above.
Isolated thoracic aortic rings
Thoracic aortic rings (approximately 4 mm in length) were suspended with a resting tension of 10 mN (Brown et al, 1991) . Cumulative concentration-response curves were performed for noradrenaline and either acetylcholine or sodium nitroprusside in the presence of a submaximal contraction to noradrenaline. Maximal contraction was recorded as that produced by addition of isotonic potassium chloride (100 mM).
Collagen distribution by picrosirius red staining and laser confocal microscopy
All experimental animals had the major organs removed and weighed. From the organs removed, the left ventricle and septum underwent histological analysis. 
Data analysis
All results are given as mean ± SEM. The negative log EC 50 of the increase in force of contraction in mN was determined from the concentration giving half-maximal responses in individual concentration-response curves. These results were analyzed by two-way analysis of variance followed by the Duncan test to determine differences between treatment groups and by paired or unpaired t-tests as appropriate; p<0.05 was considered significant.
Drugs
Deoxycorticosterone acetate, heparin, noradrenaline, acetylcholine and sodium (Table 1) .
DOCA-salt rats showed an increasing degree of left ventricular hypertrophy during the study period as evidenced by left ventricular wet weights relative to body weight and left ventricular mass derived from echocardiography (Table 1 ). This increase in left ventricular mass was supported by a decrease in left ventricular internal diameter indicating concentric cardiac hypertrophy (Table 1) . Treatment from day 14 with A-127722 prevented further increases in these parameters (Table 1 ). In contrast, the increased weights of the right ventricle and remnant kidney were not affected by A-127722 treatment (Table 1) . Thoracic aortic wall thicknesses and aortic blood flow velocities were increased by DOCA-salt treatment; A-127722 treatment prevented and reversed these changes (Table 1) . DOCA-salt rats showed increased left ventricular perivascular and interstitial collagen following 2 weeks of hypertension with further increases occurring 4 weeks after induction (Table 1) . Treatment from day 14 with A-127722 prevented this further increase (Table 1) . As a functional measure of left ventricular remodelling, diastolic stiffness obtained from the isolated Langendorff heart preparation was significantly increased in the DOCA-salt hypertensive rat after 2 weeks and further increased after 4 weeks. This increase in cardiac stiffness was completely prevented and reversed by A-127722 treatment for the last 14 days (Table 1) . ED1-positive monocyte/macrophages were found in the left ventricle of UNX rats in low numbers; there was a marked increase in DOCA-salt rats (figure 4). These cells were usually found as clusters of cells located at scar sites and throughout the interstitium. Treatment with A-127722 significantly reduced macrophage infiltration within scar sites and almost completely prevented macrophage infiltration into the left ventricular interstitium of DOCA-salt rats.
Echocardiographic assessment showed that A-127722 failed to alter the increased ejection fraction and decreased cardiac output observed in DOCA-salt hypertensive rats ( Table 1 ). The lack of significant improvement in systolic function by A-127722 in vivo was supported by contractility studies on isolated Langendorff hearts. DOCAsalt hearts showed a decreased +dP/dt that was unaltered by A-127722 treatment (Table 1 ). Diastolic cardiac function as defined by the E/A (early/atrial) mitral valve flow ratio showed a restrictive pattern that was prevented by treatment with A-127722 (Table 1) .
Left ventricular remodelling in DOCA-salt hearts resulted in a significant increase in action potential duration at 20% and 90% of repolarisation after 2 and 4 weeks. This was partially attenuated by A-127722 at 20% of repolarisation and significantly prevented and reversed at 50% and 90% of repolarisation ( Figure 5 ).
Isolated thoracic aortic rings from DOCA-salt rats showed a decreased absolute maximal contractile responses to noradrenaline and potassium chloride with marked endothelial dysfunction shown as markedly reduced relaxation responses to acetylcholine but unchanged relaxant responses to sodium nitroprusside ( Figure 6 ).
Treatment with A-127722 normalised these decreased responses ( Figure 6 ).
DISCUSSION
Hypertension, hypertrophy, activation of inflammatory processes, cardiac fibrosis, increased cardiac stiffness, decreased cardiac function, action potential prolongation and endothelial dysfunction have been well-described following induction of DOCAsalt hypertension in rats (Ammarguellat et al., 2001 (Ammarguellat et al., , 2002 Brown et al., 1999; Callera et al., 2004; Mirkovic et al., 2002; Momtaz et al., 1996; Nakano et al., 2003) . An increased endothelin-1 concentration acting through ET-A receptors has been shown to be a major cause of the hypertrophy and fibrosis since these changes could be prevented by administration of the selective ET-A receptor antagonists, A-127722, BMS 182874 and LU 135252 (Ammarguellat et al., 2001 (Ammarguellat et al., , 2002 Callera et al., 2004; Mulder et al., 2002) . Since A-127722 decreased monocyte/macrophage infiltration, interstitial and perivascular collagen deposition, cardiac stiffness, action potential prolongation and endothelial dysfunction in our study, our first major conclusion is that these changes in the DOCA-salt hypertensive rat are mediated predominantly by ET-A receptor activation.
In contrast to these consistent responses reported with selective ET-A receptor antagonists, the non-selective endothelin receptor antagonists, bosentan and SB 209670, either prevent or have no effect on cardiovascular remodelling (Mulder et al., 1997; Øie et al., 2002) . ET-B receptor activation may be cardioprotective, for example by limiting the size of the infarct following coronary artery occlusion and preventing a reduction in ET-B receptors in the ischaemic zone (Crockett et al., 2004) . However, in DOCA-salt hypertensive rats, ET-1 acting through an upregulation of ET-B receptors was a potent stimulus for elevation of superoxide levels in sympathetic ganglia (Dai et al., 2004) . This suggests that selective ET-A receptor antagonism is a better therapeutic intervention than non-selective ET receptor antagonism.
In the DOCA-salt hypertensive rat, the key mechanism for the induction of cardiac and vascular damage by endothelin-1 is likely to be the augmentation of vascular and cardiac superoxide production by NADPH oxidase by activation of ET-A receptors (Callera et al., 2003; Li et al., 2003; Pu et al., 2003) . Selective blockade of ET-A receptors reduced arterial superoxide formation (Callera et al., 2003; Li et al., 2003) that was associated with improved vascular reactivity to acetylcholine (Callera et al., 2003) and decreased hypertrophic remodelling and extracellular matrix deposition (Pu et al., 2003) . Extracellular matrix deposition is strongly linked to an increased ventricular stiffness (Weber et al., 1993) . In addition, ET-1 induced cyclo-oxygenase-2 upregulation in rat endothelial cells that may contribute to superoxide generation; this upregulation was inhibited by the non-selective ET receptor antagonist, TAK044 (Sugiyama et al., 2004) . ET-1-induced signalling events in vascular smooth muscle cells have been shown to critically depend on reactive oxygen species (Daou & Srivastava, 2004) . Further, both hypertension and vascular production of superoxide were attenuated by the selective ET-A receptor antagonist, ABT-627 (5 mg kg -1 day -1 )
in ET-B receptor-deficient rats (Elmarakby et al., 2004) . Suppression of superoxide formation by sesamin also markedly decreased the impaired vasodilator responses to acetylcholine in DOCA-salt hypertensive rats (Nakano et al., 2003) . Thus, oxidative stress induced by endothelin-1 via ET-A receptors is likely to play an important role in both cardiac and endothelial dysfunction in the DOCA-salt hypertensive rat.
The same mechanism may be involved in the electrical remodelling in the DOCA-salt hypertensive rat heart. Reactive oxygen species such as superoxide mediated the prolongation of the action potential duration of the cytokine, tissue necrosis factor-α, by a functional depression of the delayed rectifier K + -current (Wang et al., 2004) .
Endothelin-1 increased action potential duration in cardiac myocytes (Yorikane et al., 1991) , probably due to an increased Ca 2+ mobilisation and decreased K + channel currents (Washizuka et al., 1997) . Chronic treatment with the selective ET-A receptor antagonist, TA-0201 (approximately 1.3 mg kg -1 day -1 ), inhibited electrical remodelling including action potential duration prolongation and suppressed ventricular arrhythmias in cardiomyopathic hamster hearts (Matsumoto et al., 2002) .
Acute ET-A receptor blockade with BQ-123 (0.4 mg kg -1 ) reduced the incidence of ventricular tachycardia and fibrillation during the first 24 hours after coronary artery ligation through a decrease in dispersal of repolarization (Baltogiannis et al., 2005) . Duru et al. (2001) have discussed the proposed mechanisms and therapeutic potential of endothelin antagonists as antiarrhythmic drugs. These results strongly suggest that administration of A-127722 as a selective ET-A receptor antagonist in our study reversed the prolongation of the action potential duration by suppressing the increased superoxide production following activation of ET-A receptors in the DOCA-salt hypertensive rat.
The second major conclusion of this study is that selective ET-A receptor antagonism can reverse some of the existing damage to the heart and blood vessels in addition to preventing further damage. Cardiac and vascular damage in the DOCA-salt hypertensive rat is clearly evident after two weeks and increases in the following two weeks. While administration of an ET-A antagonist has been shown to prevent cardiovascular damage when given from the initiation of DOCA-salt hypertension, our results show that the cardiovascular changes produced in the first two weeks can be reversed by ET-A receptor blockade during the next two weeks. In particular, the decreased interstitial collagen should improve both myocardial relaxation and contraction while the decreased perivascular collagen should improve nutrient distribution and removal of waste products. We have shown previously using a similar reversal protocol that the antiinflammatory compound, pirfenidone, reversed the cardiovascular changes in DOCA-salt hypertensive rats (Mirkovic et al., 2002) and in streptozotocin-diabetic rats (Miric et al., 2001 ).
Thus, an increased endothelin production is likely to be responsible for the cardiac and vascular changes in the DOCA-salt hypertensive rat probably through activation of superoxide production by NADPH oxidase. Further, selective blockade of ET-A receptors both reverses and prevents these cardiovascular changes and leads to an improved cardiac and vascular function. 
